Detailed TOC of Global PD L1 Biomarker Testing Market Report, Competitive Landscape, Market Size, Regional Status and Prospect
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global PD L1 Biomarker Testing Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 PD L1 Biomarker Testing Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 PD L1 Biomarker Testing Business Mode and Production Process
2.3.1 PD L1 Biomarker Testing Business Mode Analysis
2.3.2 Production Process Analysis
2.4 PD L1 Biomarker Testing Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of PD L1 Biomarker Testing
2.4.2 Raw Material Cost of PD L1 Biomarker Testing
2.4.3 Labor Cost of PD L1 Biomarker Testing
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global PD L1 Biomarker Testing Revenue and Market Share by Manufacturer (2020-2025)
4.2 Global PD L1 Biomarker Testing Sales Volume and Market Share by Manufacturer (2020-2025)
4.3 Global PD L1 Biomarker Testing Price by Manufacturer (2020-2025)
4.4 PD L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of PD L1 Biomarker Testing, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of PD L1 Biomarker Testing, Product Offered and Application
4.7 PD L1 Biomarker Testing Market Competitive Situation and Trends
4.7.1 PD L1 Biomarker Testing Market Concentration Rate
4.7.2 Global Top 3 and Top 6 PD L1 Biomarker Testing Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global PD L1 Biomarker Testing Market Historical Development by Geographic Region (2020-2025)
5.1 Global PD L1 Biomarker Testing Market Historical Sales Volume by Geographic Region (2020-2025)
5.2 Global PD L1 Biomarker Testing Market Historical Revenue by Geographic Region (2020-2025)
5.3 North America PD L1 Biomarker Testing Market Status by Country (2020-2025)
5.3.1 North America PD L1 Biomarker Testing Sales Volume by Country (2020-2025)
5.3.2 North America PD L1 Biomarker Testing Revenue by Country (2020-2025)
5.3.3 United States PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.3.4 Canada PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4 Europe PD L1 Biomarker Testing Market Status by Country (2020-2025)
5.4.1 Europe PD L1 Biomarker Testing Sales Volume by Country (2020-2025)
5.4.2 Europe PD L1 Biomarker Testing Revenue by Country (2020-2025)
5.4.3 Germany PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4.4 France PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4.5 United Kingdom PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4.6 Spain PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4.7 Russia PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.4.8 Poland PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5 Asia Pacific PD L1 Biomarker Testing Market Status by Country (2020-2025)
5.5.1 Asia Pacific PD L1 Biomarker Testing Sales Volume by Country (2020-2025)
5.5.2 Asia Pacific PD L1 Biomarker Testing Revenue by Country (2020-2025)
5.5.3 China PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5.4 Japan PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5.5 South Korea PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5.6 Southeast Asia PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5.7 India PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.5.8 Australia PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.6 Latin America PD L1 Biomarker Testing Market Status by Country (2020-2025)
5.6.1 Latin America PD L1 Biomarker Testing Sales Volume by Country (2020-2025)
5.6.2 Latin America PD L1 Biomarker Testing Revenue by Country (2020-2025)
5.6.3 Mexico PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.6.4 Brazil PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.7 Middle East and Africa PD L1 Biomarker Testing Market Status by Country (2020-2025)
5.7.1 Middle East and Africa PD L1 Biomarker Testing Sales Volume by Country (2020-2025)
5.7.2 Middle East and Africa PD L1 Biomarker Testing Revenue by Country (2020-2025)
5.7.3 GCC PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
5.7.4 South Africa PD L1 Biomarker Testing Sales Volume, Revenue and Growth (2020-2025)
6 Global PD L1 Biomarker Testing Market Historical Development by Product Type (2020-2025)
6.1 PD L1 Biomarker Testing Definition by Type
6.2 Global PD L1 Biomarker Testing Historical Sales Volume by Product Type (2020-2025)
6.3 Global PD L1 Biomarker Testing Historical Revenue by Product Type (2020-2025)
6.4 Global PD L1 Biomarker Testing Historical Price by Product Type (2020-2025)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2025)
6.5.1 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of PD-L1 (22C3) (2020-2025)
6.5.2 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of PD-L1(28-8) (2020-2025)
6.5.3 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of PD-L1 (SP142) (2020-2025)
6.5.4 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of PD-L1 (SP263) (2020-2025)
6.5.5 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of Others (2020-2025)
7 Global PD L1 Biomarker Testing Market Historical Development by End User (2020-2025)
7.1 Downstream Market Overview
7.2 Global PD L1 Biomarker Testing Historical Sales Volume by End User (2020-2025)
7.3 Global PD L1 Biomarker Testing Historical Revenue by End User (2020-2025)
7.4 Global PD L1 Biomarker Testing Historical Price by End User (2020-2025)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2025)
7.5.1 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of Hospital (2020-2025)
7.5.2 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of Diagnostic Center (2020-2025)
7.5.3 Global PD L1 Biomarker Testing Historical Sales Volume, Revenue and Growth Rate of Others (2020-2025)
8 Leading Companies Profiles
8.1 Innovent
8.1.1 Innovent Corporation Information
8.1.2 Innovent - PD L1 Biomarker Testing Product Portfolio and Specification
8.1.3 Innovent Performance Analysis (2020-2025)
8.1.4 Innovent Business and Markets Served
8.1.5 Innovent Recent Developments
8.2 Merck
8.2.1 Merck Corporation Information
8.2.2 Merck - PD L1 Biomarker Testing Product Portfolio and Specification
8.2.3 Merck Performance Analysis (2020-2025)
8.2.4 Merck Business and Markets Served
8.2.5 Merck Recent Developments
8.3 Ono Pharmaceutical
8.3.1 Ono Pharmaceutical Corporation Information
8.3.2 Ono Pharmaceutical - PD L1 Biomarker Testing Product Portfolio and Specification
8.3.3 Ono Pharmaceutical Performance Analysis (2020-2025)
8.3.4 Ono Pharmaceutical Business and Markets Served
8.3.5 Ono Pharmaceutical Recent Developments
8.4 AstraZeneca
8.4.1 AstraZeneca Corporation Information
8.4.2 AstraZeneca - PD L1 Biomarker Testing Product Portfolio and Specification
8.4.3 AstraZeneca Performance Analysis (2020-2025)
8.4.4 AstraZeneca Business and Markets Served
8.4.5 AstraZeneca Recent Developments
8.5 Agilent Technologies
8.5.1 Agilent Technologies Corporation Information
8.5.2 Agilent Technologies - PD L1 Biomarker Testing Product Portfolio and Specification
8.5.3 Agilent Technologies Performance Analysis (2020-2025)
8.5.4 Agilent Technologies Business and Markets Served
8.5.5 Agilent Technologies Recent Developments
8.6 Junshi Biosciences
8.6.1 Junshi Biosciences Corporation Information
8.6.2 Junshi Biosciences - PD L1 Biomarker Testing Product Portfolio and Specification
8.6.3 Junshi Biosciences Performance Analysis (2020-2025)
8.6.4 Junshi Biosciences Business and Markets Served
8.6.5 Junshi Biosciences Recent Developments
8.7 Bristol-Myers Squibb
8.7.1 Bristol-Myers Squibb Corporation Information
8.7.2 Bristol-Myers Squibb - PD L1 Biomarker Testing Product Portfolio and Specification
8.7.3 Bristol-Myers Squibb Performance Analysis (2020-2025)
8.7.4 Bristol-Myers Squibb Business and Markets Served
8.7.5 Bristol-Myers Squibb Recent Developments
8.8 Regeneron
8.8.1 Regeneron Corporation Information
8.8.2 Regeneron - PD L1 Biomarker Testing Product Portfolio and Specification
8.8.3 Regeneron Performance Analysis (2020-2025)
8.8.4 Regeneron Business and Markets Served
8.8.5 Regeneron Recent Developments
8.9 Roche
8.9.1 Roche Corporation Information
8.9.2 Roche - PD L1 Biomarker Testing Product Portfolio and Specification
8.9.3 Roche Performance Analysis (2020-2025)
8.9.4 Roche Business and Markets Served
8.9.5 Roche Recent Developments
8.10 Hengrui Medicine
8.10.1 Hengrui Medicine Corporation Information
8.10.2 Hengrui Medicine - PD L1 Biomarker Testing Product Portfolio and Specification
8.10.3 Hengrui Medicine Performance Analysis (2020-2025)
8.10.4 Hengrui Medicine Business and Markets Served
8.10.5 Hengrui Medicine Recent Developments
9 Global PD L1 Biomarker Testing Market Forecast by Product Type and End User (2025-2033)
9.1 Global PD L1 Biomarker Testing Market Forecast by Product Type (2025-2033)
9.1.1 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of PD-L1 (22C3) (2025-2033)
9.1.2 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of PD-L1(28-8) (2025-2033)
9.1.3 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of PD-L1 (SP142) (2025-2033)
9.1.4 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of PD-L1 (SP263) (2025-2033)
9.1.5 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of Others (2025-2033)
9.2 Global PD L1 Biomarker Testing Market Forecast by End User (2025-2033)
9.2.1 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of Hospital (2025-2033)
9.2.2 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of Diagnostic Center (2025-2033)
9.2.3 Global PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth Rate of Others (2025-2033)
10 Global PD L1 Biomarker Testing Market Forecast by Geographic Region (2025-2033)
10.1 Global PD L1 Biomarker Testing Sales Volume and Revenue Forecast by Geographic Region (2025-2033)
10.2 North America PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.1 United States PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.2 Canada PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3 Europe PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.1 Germany PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.2 France PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.3 United Kingdom PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.4 Spain PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.5 Russia PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.6 Poland PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4 Asia Pacific PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.1 China PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.2 Japan PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.3 South Korea PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.4 Southeast Asia PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.5 India PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.6 Australia PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5 Latin America PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.1 Mexico PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.2 Brazil PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6 Middle East and Africa PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.1 GCC PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.2 South Africa PD L1 Biomarker Testing Sales Volume, Revenue Forecast and Growth (2025-2033)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Download FREE Sample Report
